- Home
- PRTA vs NMCO Comparison
PRTA vs NMCO Comparison
Compare PRTA & NMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- NMCO
- Stock Information
- Founded
- PRTA 2012
- NMCO 2019
- Country
- PRTA Ireland
- NMCO United States
- Employees
- PRTA N/A
- NMCO N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- NMCO Finance/Investors Services
- Sector
- PRTA Health Care
- NMCO Finance
- Exchange
- PRTA Nasdaq
- NMCO Nasdaq
- Market Cap
- PRTA 765.2M
- NMCO 614.1M
- IPO Year
- PRTA N/A
- NMCO N/A
- Fundamental
- Price
- PRTA $15.56
- NMCO $11.08
- Analyst Decision
- PRTA Buy
- NMCO
- Analyst Count
- PRTA 8
- NMCO 0
- Target Price
- PRTA $46.00
- NMCO N/A
- AVG Volume (30 Days)
- PRTA 336.3K
- NMCO 207.6K
- Earning Date
- PRTA 02-20-2025
- NMCO 01-01-0001
- Dividend Yield
- PRTA N/A
- NMCO 5.43%
- EPS Growth
- PRTA N/A
- NMCO N/A
- EPS
- PRTA N/A
- NMCO N/A
- Revenue
- PRTA $135,157,000.00
- NMCO N/A
- Revenue This Year
- PRTA $56.89
- NMCO N/A
- Revenue Next Year
- PRTA N/A
- NMCO N/A
- P/E Ratio
- PRTA N/A
- NMCO N/A
- Revenue Growth
- PRTA 47.92
- NMCO N/A
- 52 Week Low
- PRTA $11.70
- NMCO $8.52
- 52 Week High
- PRTA $31.03
- NMCO $11.64
- Technical
- Relative Strength Index (RSI)
- PRTA 59.65
- NMCO 55.12
- Support Level
- PRTA $13.69
- NMCO $11.00
- Resistance Level
- PRTA $15.09
- NMCO $11.24
- Average True Range (ATR)
- PRTA 0.91
- NMCO 0.11
- MACD
- PRTA 0.13
- NMCO -0.01
- Stochastic Oscillator
- PRTA 68.56
- NMCO 43.57
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
About NMCO Nuveen Municipal Credit Opportunities Fund
Nuveen Municipal Credit Opps Fund is a closed-end fund. The fund's objective is to provide a high level of current income exempt from regular U.S. federal income tax and secondarily, total return. It invests in high yielding, low-to medium-quality municipal securities and uses leverage.